The global cell therapy technologies market is projected to reach USD 8.0 billion by 2027 from USD 4.0 billion in 2022, at a CAGR of 14.6% during the forecast period. Market growth is driven mainly by increasing research in regenerative medicine along with stem cell research, cancer research, and cell biology research.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
Cell therapy technologies encompass a wide range of techniques and tools that enable the isolation, expansion, modification, and delivery of therapeutic cells. These technologies are crucial for the successful development and administration of cell-based therapies.
Key components of the cell therapy technologies market include:
Cell Sourcing and Isolation: Techniques for obtaining and isolating specific cell types from various sources, such as bone marrow, peripheral blood, umbilical cord blood, or induced pluripotent stem cells (iPSCs).
Cell Expansion and Culture: Methods for growing and expanding isolated cells in the laboratory, often using specialized culture media, bioreactors, and scaffolds to support cell growth and differentiation.
Cell Modification and Engineering: Genetic engineering and manipulation techniques to modify therapeutic cells for enhanced efficacy, safety, or targeted delivery. This can include gene editing technologies like CRISPR-Cas9 or the introduction of specific genes or gene constructs.
Quality Control and Testing: Assays and technologies to assess the quality, purity, potency, and safety of therapeutic cells before they are administered to patients. This ensures that the cells meet rigorous standards and regulatory requirements.
Cryopreservation and Cell Banking: Methods for freezing and storing therapeutic cells for long-term preservation and future use. Cryopreservation allows cells to be stored at ultra-low temperatures while maintaining their viability and functionality.
Cell Delivery and Administration: Techniques and devices for delivering therapeutic cells to the patient's body, including direct injections, intravenous infusions, or implantation through surgical procedures.
“The stem cells segment accounted for the second largest share of the cell type segment in the cell therapy technologies market.”
Rising awareness regarding the use of stem cells in the treatment of various diseases and the growing focus of players on stem cell research are driving the growth of this market segment. Rising collaboration between universities and biotechnology & biopharmaceutical companies for stem cell research and government support (availability of funding) are other important drivers.
The Asia Pacific region is the fastest-growing region of the cell therapy technologies market
The Asia Pacific is estimated to be the fastest-growing segment of the market. The growth of the cell therapy technologies market of the region is mostly driven by their low labor and manufacturing costs, which has drawn huge investments by biopharma giants to these countries. The increasing disposable income, growing prevalence of lifestyle and age-related chronic diseases also contribute to the high growth of the regional market.
Key Market Players
Key players in the Market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Becton, Dickinson and Company (US), Fresenius SE & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte Inc. (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), TrakCel (UK), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), GPI Iberia (Spain), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Manufacturing Corporation (US).
Inquiry before buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=213334978
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing
Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441